Nuvation Bio Inc. — Director's Dealing 2026

Mar 4, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2026-02-27

Reporting Person: Wentworth Kerry (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-27	Stock Option (Right to Buy)	$5.91	A	748130	Acquired	2036-02-26	Class A Common Stock (748130)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	53000	Direct

Footnotes

F1: Includes 3,000 shares acquired on November 19, 2025 under the 2021 Employee Stock Purchase Plan.

F2: Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.